Robert Lafyatis conducts interdisciplinary study in the fields of Internal medicine and Endocrinology through his works. Robert Lafyatis integrates several fields in his works, including Endocrinology and Internal medicine. Transforming growth factor beta is closely attributed to Cell biology in his work. As part of his studies on Cell biology, Robert Lafyatis frequently links adjacent subjects like Transforming growth factor. In his articles, Robert Lafyatis combines various disciplines, including Transforming growth factor and Epidermal growth factor. Epidermal growth factor and Transforming growth factor beta are two areas of study in which Robert Lafyatis engages in interdisciplinary research. His research links Transforming growth factor, beta 3 with Receptor. His study brings together the fields of TGF alpha and Transforming growth factor, beta 3. His research on TGF alpha often connects related areas such as Receptor.
His Synovial membrane research extends to the thematically linked field of Immunology. Robert Lafyatis performs multidisciplinary study in Synovial membrane and Cytokine in his work. His study deals with a combination of Cytokine and Collagenase. He integrates many fields in his works, including Collagenase and Fibroblast. He integrates Fibroblast and Platelet-derived growth factor in his studies. He undertakes interdisciplinary study in the fields of Platelet-derived growth factor and Epidermal growth factor through his works. Many of his studies on Epidermal growth factor apply to Receptor as well. He applies his multidisciplinary studies on Receptor and Enzyme in his research. Robert Lafyatis undertakes multidisciplinary studies into Enzyme and Cell growth in his work.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues.
Carly G.K. Ziegler;Samuel J. Allon;Sarah K. Nyquist;Ian M. Mbano.
Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex.
Seong Jin Kim;Peter Angel;Robert Lafyatis;Kazue Hattori.
Molecular and Cellular Biology (1990)
Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial
Dinesh Khanna;Christopher P Denton;Angelika Jahreis;Jacob M van Laar.
The Lancet (2016)
Generation of Transgene‐Free Lung Disease‐Specific Human Induced Pluripotent Stem Cells Using a Single Excisable Lentiviral Stem Cell Cassette
Aba Somers;Jyh‐Chang Jean;Cesar A. Sommer;Amel Omari.
Stem Cells (2010)
Anchorage-independent growth of synoviocytes from arthritic and normal joints. Stimulation by exogenous platelet-derived growth factor and inhibition by transforming growth factor-beta and retinoids.
R Lafyatis;E F Remmers;A B Roberts;D E Yocum.
Journal of Clinical Investigation (1989)
Localization and actions of transforming growth factor-beta s in the embryonic nervous system.
K.C. Flanders;G. Ludecke;S. Engels;D.S. Cissel.
Transforming growth factor beta isoforms in the adult rat central and peripheral nervous system
K. Unsicker;K.C. Flanders;D.S. Cissel;R. Lafyatis.
Partial Inhibition of Integrin αvβ6 Prevents Pulmonary Fibrosis without Exacerbating Inflammation
Gerald S. Horan;Susan Wood;Victor Ona;Dan Jun Li.
American Journal of Respiratory and Critical Care Medicine (2008)
Proteome-wide Analysis and CXCL4 as a Biomarker in Systemic Sclerosis
L. Van Bon;L. Van Bon;A. J. Affandi;A. J. Affandi;J. Broen;J. Broen;R. B. Christmann.
The New England Journal of Medicine (2014)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I interferons and toll-like receptor agonists.
Michael R. York;Taro Nagai;Alyson J. Mangini;Raphaël Lemaire.
Arthritis & Rheumatism (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: